Quick Answer
ANI PHARMACEUTICALS INC reported Net Income Loss of $78.34 million for the year ending 2025.
- ANI PHARMACEUTICALS INC showed an increase of +522.9% in Net Income Loss from 2024 to 2025.
- This data is from ANI PHARMACEUTICALS INC's annual report (Form 10-K), filed with the SEC on February 27, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 14 years of available data (2012 to 2025), ANI PHARMACEUTICALS INC's Net Income Loss has grown by 5,301.7%.
- Historical annual values: Fiscal year 2025: $78.34 million | Fiscal year 2024: -$18.52 million | Fiscal year 2023: $18.78 million | Fiscal year 2022: -$47.90 million | Fiscal year 2021: -$42.60 million | Fiscal year 2020: -$22.55 million | Fiscal year 2019: $6.09 million | Fiscal year 2018: $15.49 million | Fiscal year 2017: -$1.08 million | Fiscal year 2016: $3.93 million | Fiscal year 2015: $15.38 million | Fiscal year 2014: $28.75 million | Fiscal year 2013: $301.0 thousand | Fiscal year 2012: -$1.51 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: